Trial Profile
Evaluating pharmacokinetics of aritaprevir, Ombitasvir, Ritonavir and Ribavirin in Subjects with Hcv Genotype 4 Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Paritaprevir (Primary) ; Ombitasvir; Ribavirin; Ritonavir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 06 Aug 2015 New trial record